Clinitech Laboratory Ltd
BSE: 544220
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2026 | Q4 FY2025 | Q2 FY2025 |
|---|---|---|---|
| INCOME | |||
| Revenue | 5.08+22.1% | 4.16+2.0% | 4.08 |
| Other Income | 0.11-36.8% | 0.17+222.2% | 0.05 |
| Total Income | 5.19+19.8% | 4.33+4.9% | 4.13 |
| EXPENSES | |||
| Expenditure | 4.84+19.8% | 4.04+4.3% | 3.87 |
| Tax | 0.05-58.2% | 0.12+212.8% | 0.04 |
| PROFIT | |||
| PBT | 0.35+19.0% | 0.29+13.5% | 0.26 |
| Net Profit | 0.30+72.4% | 0.17-21.3% | 0.22 |
| KEY METRICS | |||
| OPM % | -1.12%-0.28pp | -0.84%+2.67pp | -3.51% |
| NPM % | 5.78%+1.76pp | 4.02%-1.33pp | 5.35% |
| EPS | 1.32+59.0% | 0.83+388.2% | 0.17 |
Corporate Events
Board MeetingCTLLAB
202628May
Board Meeting
To consider and approve the Audited Standalone & Consolidate…
BSE Filing ↗ Board MeetingCTLLAB
202627Jan
Board Meeting
Formation of a subsidiary, Re-constitution of Internal Compl…
BSE Filing ↗ Board MeetingCTLLAB
202512Nov
Board Meeting
Consider and approve the Un-Audited Financial Result of the …
BSE Filing ↗ Board MeetingCTLLAB
202413Nov
Board Meeting
consider and approve Un-Audited Financial Results of the Com…
BSE Filing ↗